BEIJING, June 1, 2022
/PRNewswire/ -- Concord Medical Services Holdings Limited
("Concord Medical" or the "Company") (NYSE: CCM), a
healthcare provider specialized in cancer treatment, research,
education and prevention by establishing proton centers and cancer
hospitals and operating an extensive network of radiotherapy and
diagnostic imaging centers in China, today announced
that its subsidiary, Concord Healthcare Group Co., Ltd.
("Concord Healthcare"), a company incorporated in
China, filed an application (the
"Application") to list a minority stake of its shares (the
"Concord Healthcare Shares") on The Stock
Exchange of Hong Kong Limited (the "Hong Kong Stock
Exchange") (the "Listing") on May
31, 2022. The Application is accessible through the Hong
Kong Stock Exchange's website at www.hkexnews.hk.
Shareholders are cautioned not to give undue reliance on this
announcement. There can be no assurance whether and when the
Listing will be completed. The Listing is subject to the approval
from the Listing Committee of the HKSE for listing of, and
permission to deal in, the Concord Healthcare Shares, and the final
decisions of the respective board of directors of the Company and
Concord Healthcare with respect to a number of factors, including
but not limited to, valuation and prevailing market conditions.
This announcement is not intended to, and does not, constitute
an offer to sell or a solicitation of an offer to purchase any
securities, in the United States
or elsewhere, and it is not intended to, and does not, constitute
an offer, solicitation or sale of any securities in any state or
jurisdiction in which such an offer, solicitation or sale would be
unlawful.
About Concord Healthcare
Concord Healthcare is a leading oncology healthcare total
solution platform in China
featuring the research and application of advanced oncology
diagnostic and treatment technologies, and one of the few private
medical institutions in China
owning multiple proton therapy treatment rooms. Concord Healthcare
serves both cancer patients through self-owned medical institutions
and empowerment to third-party medical institutions through network
business. In its self-owned medical institutions, Concord
Healthcare provides a full spectrum of oncology healthcare services
to cancer patients across the entire care continuum, leveraging its
high-caliber multidisciplinary team specialists and robust
diagnosis and treatment capabilities featuring precision radiation
therapy. Through its network business, Concord Healthcare empowers
a widespread network of enterprise customers, primarily hospitals,
with integrated oncology-related services, including primarily
medical solution, management and technical support, and operating
lease.
About Concord Medical
Concord Medical Services Holdings Limited (NYSE: CCM) is a
healthcare provider featuring a full cycle of premium oncology
services including cancer diagnosis, treatment, education and
prevention. The Company focuses on providing multidisciplinary
cancer care in all aspects of oncology healthcare services in its
cancer hospitals and equipping them with technologically advanced
equipment such as the state-of-the-art proton therapy system. The
Company is striving to improve the quality and accessibility of
cancer care through its network of self-owned cancer hospitals and
clinics as well as partnered hospitals across China. For more
information, please see http://ir.ccm.cn.
Safe Harbor Statement
This announcement contains forward-looking statements. These
forward-looking statements can be identified by words or phrases
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar expressions.
Forward-looking statements are inherently subject to uncertainties
and contingencies beyond the Company's control and based upon
premises with respect to future business decisions, which are
subject to change. A number of important factors could cause actual
results to differ materially from those contained in any
forward-looking statement. The Company does not undertake any
obligation to update any forward-looking statement, except as
required under applicable law.
View original
content:https://www.prnewswire.com/news-releases/concord-medical-announces-its-subsidiarys-application-filing-for-potential-listing-on-the-stock-exchange-of-hong-kong-limited-301559312.html
SOURCE Concord Medical Services Holdings Limited